Connect Biopharmaceuticals, a clinical-stage biotech medicine developer, has completed a US$55 million series B round of financing, led by private equity Advantech Capital, according to a company announcement released today. Current investors Qiming Venture Partners, Northern Light Venture Capital, and Cowin Venture, also participate in the round. CEC Capital has acted as the exclusive financial adviser for […]

Chinese Drug Developer Firm Connect Biopharmaceuticals Completes $55 Million Series B Round appeared first on China Money Network.